Publications by authors named "J Turuk"
This research delves into the evolving dynamics of antibiogram trends, the diversity of antibiotic resistance genes and antibiotic efficacy against Vibrio cholerae strains that triggered the cholera outbreak 2022 in Odisha, India. The study will provide valuable insights managing antimicrobial resistance during cholera outbreaks. Eighty V.
View Article and Find Full Text PDFBackground: India relies primarily on direct smear microscopy for tuberculosis (TB) diagnosis. However, the low sensitivity of smear microscopy emphasizes the need to improve its performance. We recently described the development of 'TB' kit which showed improved performance over direct smear microscopy at National Reference Laboratories (NRLs) in India.
View Article and Find Full Text PDFThis study evaluated the performance of cobas MTB and cobas MTB-RIF/INH for the diagnosis of tuberculosis and detection of rifampicin (RIF) and isoniazid (INH) resistance. Adults presenting with pulmonary tuberculosis symptoms were recruited in South Africa, Moldova, and India. Performance of cobas MTB was assessed against culture, whereas cobas MTB-RIF/INH was assessed using phenotypic drug susceptibility testing and whole-genome sequencing as composite reference standards.
View Article and Find Full Text PDFArticle Synopsis
- The study focuses on the prevalence and impact of diabetes mellitus (DM) and HIV among tuberculosis (TB) cases in Odisha, India, during 2019, highlighting the interconnected health issues in the region.
- Findings reveal that 7.6% of TB patients had DM, while only 1.2% had HIV, and a very small percentage (0.08%) had both conditions alongside TB.
- Interestingly, patients with TB and DM generally had better treatment outcomes (88.2% favorable) compared to those with TB and HIV (82.3% favorable), suggesting differing impacts of these comorbidities on TB treatment success.
Article Synopsis
- - Mucormycosis, the third most common invasive fungal infection after candidiasis and aspergillosis, is garnering attention as a notifiable disease due to its rising cases in both developed and developing countries, particularly in India, where the incidence is notably high.
- - The disease presents various clinical forms, with rhino-orbital-cerebral mucormycosis being the most common in India, while pulmonary mucormycosis is more prevalent globally; diagnosis relies on clinical evaluations and laboratory tests, although there are challenges in achieving rapid results.
- - Effective treatment involves a combination of addressing underlying health risks, administering antifungal medications like Liposomal Amphotericin B and Posaconazole, and